[{"name":"R4-2220061","title":"Topic summary for [105][215] FR2_multiRx_RRM_part1","source":"Moderator (Vivo)","contact":"Carolyn Taylor","contact-id":90657,"tdoctype":"other","for":"Information","abstract":"[105][215] FR2_multiRx_RRM_part1","secretary_remarks":"[105][215] FR2_multiRx_RRM_part1","agenda_item_sort_order":299,"ainumber":"8.8.4","ainame":"Moderator summary and conclusions","tdoc_agenda_sort_order":0,"status":"noted","reservation_date":"2022-09-11 18:38:48","uploaded":"2022-11-17 14:51:18","revisionof":"","revisedto":"","release":"","crspec":"","crspecversion":"","workitem":"","crnumber":"","crrevision":"","crcategory":"","tsg_crp":"","lsreplyto":"","lsto":"","Cc":"","lsoriginalls":"","lsreply":"","link":"https:\/\/www.3gpp.org\/ftp\/TSG_RAN\/WG4_Radio\/TSGR4_105\/Docs\/R4-2220061.zip","group":"R4","meeting":"R4-105","year":2022,"uicc_affected":"","me_affected":"","ran_affected":"","cn_affected":"","clauses_affected":"","crsinpack":null,"crsinpacknumber":0},
{"name":"R4-2220062","title":"Topic summary for [105][216] FR2_multiRx_RRM_part2","source":"Moderator (Qualcomm)","contact":"Carolyn Taylor","contact-id":90657,"tdoctype":"other","for":"Information","abstract":"[105][216] FR2_multiRx_RRM_part2","secretary_remarks":"[105][216] FR2_multiRx_RRM_part2","agenda_item_sort_order":299,"ainumber":"8.8.4","ainame":"Moderator summary and conclusions","tdoc_agenda_sort_order":0,"status":"noted","reservation_date":"2022-09-11 18:38:48","uploaded":"2022-11-12 14:01:30","revisionof":"","revisedto":"","release":"","crspec":"","crspecversion":"","workitem":"","crnumber":"","crrevision":"","crcategory":"","tsg_crp":"","lsreplyto":"","lsto":"","Cc":"","lsoriginalls":"","lsreply":"","link":"https:\/\/www.3gpp.org\/ftp\/TSG_RAN\/WG4_Radio\/TSGR4_105\/Docs\/R4-2220062.zip","group":"R4","meeting":"R4-105","year":2022,"uicc_affected":"","me_affected":"","ran_affected":"","cn_affected":"","clauses_affected":"","crsinpack":null,"crsinpacknumber":0},
{"name":"R4-2220063","title":"Topic summary for [105][217] FR2_multiRx_RRM_part3","source":"Moderator (Ericsson)","contact":"Carolyn Taylor","contact-id":90657,"tdoctype":"other","for":"Information","abstract":"[105][217] FR2_multiRx_RRM_part3","secretary_remarks":"[105][217] FR2_multiRx_RRM_part3","agenda_item_sort_order":299,"ainumber":"8.8.4","ainame":"Moderator summary and conclusions","tdoc_agenda_sort_order":0,"status":"noted","reservation_date":"2022-09-11 18:38:48","uploaded":"2022-11-12 14:01:30","revisionof":"","revisedto":"","release":"","crspec":"","crspecversion":"","workitem":"","crnumber":"","crrevision":"","crcategory":"","tsg_crp":"","lsreplyto":"","lsto":"","Cc":"","lsoriginalls":"","lsreply":"","link":"https:\/\/www.3gpp.org\/ftp\/TSG_RAN\/WG4_Radio\/TSGR4_105\/Docs\/R4-2220063.zip","group":"R4","meeting":"R4-105","year":2022,"uicc_affected":"","me_affected":"","ran_affected":"","cn_affected":"","clauses_affected":"","crsinpack":null,"crsinpacknumber":0},
{"name":"R4-2220111","title":"Topic summary for [105][131] FR2_multiRx_UERF_part1","source":"Moderator (Qualcomm)","contact":"Carolyn Taylor","contact-id":90657,"tdoctype":"other","for":"Information","abstract":"[105][131] FR2_multiRx_UERF_part1","secretary_remarks":"[105][131] FR2_multiRx_UERF_part1","agenda_item_sort_order":299,"ainumber":"8.8.4","ainame":"Moderator summary and conclusions","tdoc_agenda_sort_order":0,"status":"noted","reservation_date":"2022-09-11 18:39:29","uploaded":"2022-11-12 14:01:30","revisionof":"","revisedto":"","release":"","crspec":"","crspecversion":"","workitem":"","crnumber":"","crrevision":"","crcategory":"","tsg_crp":"","lsreplyto":"","lsto":"","Cc":"","lsoriginalls":"","lsreply":"","link":"https:\/\/www.3gpp.org\/ftp\/TSG_RAN\/WG4_Radio\/TSGR4_105\/Docs\/R4-2220111.zip","group":"R4","meeting":"R4-105","year":2022,"uicc_affected":"","me_affected":"","ran_affected":"","cn_affected":"","clauses_affected":"","crsinpack":null,"crsinpacknumber":0},
{"name":"R4-2220112","title":"Topic summary for [105][132] FR2_multiRx_UERF_part2","source":"Moderator (Apple)","contact":"Carolyn Taylor","contact-id":90657,"tdoctype":"other","for":"Information","abstract":"[105][132] FR2_multiRx_UERF_part2","secretary_remarks":"[105][132] FR2_multiRx_UERF_part2","agenda_item_sort_order":299,"ainumber":"8.8.4","ainame":"Moderator summary and conclusions","tdoc_agenda_sort_order":0,"status":"noted","reservation_date":"2022-09-11 18:39:29","uploaded":"2022-11-12 14:01:30","revisionof":"","revisedto":"","release":"","crspec":"","crspecversion":"","workitem":"","crnumber":"","crrevision":"","crcategory":"","tsg_crp":"","lsreplyto":"","lsto":"","Cc":"","lsoriginalls":"","lsreply":"","link":"https:\/\/www.3gpp.org\/ftp\/TSG_RAN\/WG4_Radio\/TSGR4_105\/Docs\/R4-2220112.zip","group":"R4","meeting":"R4-105","year":2022,"uicc_affected":"","me_affected":"","ran_affected":"","cn_affected":"","clauses_affected":"","crsinpack":null,"crsinpacknumber":0}]